Petros Pharmaceuticals Inc (PTPI)
0.6885
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
0.62
-0.07
(-9.95%)
After-Hours: 20:00
Petros Pharmaceuticals Cash from Financing (Quarterly): -2.373M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.373M |
| September 30, 2023 | 14.63M |
| June 30, 2023 | -0.3632M |
| March 31, 2023 | -0.3578M |
| December 31, 2022 | -0.1851M |
| September 30, 2022 | -0.362M |
| June 30, 2022 | -0.177M |
| March 31, 2022 | -0.90M |
| December 31, 2021 | 24.02M |
| Date | Value |
|---|---|
| September 30, 2021 | -1.685M |
| June 30, 2021 | -1.636M |
| March 31, 2021 | -2.126M |
| December 31, 2020 | 20.99M |
| September 30, 2020 | 2.505M |
| June 30, 2020 | 5.43M |
| March 31, 2020 | 1.376M |
| March 31, 2019 | -4.81M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.373M
Minimum
Dec 2023
24.02M
Maximum
Dec 2021
3.674M
Average
-0.2714M
Median
Cash from Financing (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 0.001M |
| Imunon Inc | 0.0302M |
| iBio Inc | 4.005M |
| Oramed Pharmaceuticals Inc | -25.00M |
| Ocugen Inc | 0.016M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.260M |
| Free Cash Flow | -7.626M |
| Free Cash Flow Per Share (Quarterly) | -0.9504 |
| Free Cash Flow to Equity (Quarterly) | -1.886M |
| Free Cash Flow to Firm (Quarterly) | -2.260M |
| Free Cash Flow Yield | -509.1% |